Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,387,790
Closed -$93.9M 37
2025
Q3
$93.9M Sell
6,387,790
-362,210
-5% -$3.69M 1.21% 21
2025
Q2
$66.3M Buy
6,750,000
+400,000
+6% +$3.31M 1.16% 19
2025
Q1
$46.2M Buy
6,350,000
+2,250,000
+55% +$19.7M 0.72% 23
2024
Q4
$32.1M Buy
+4,100,000
New +$33.8M 0.45% 29

Other funds holding ETNB

Avoro Capital Advisors's ETNB Position: Q4 2025 in Review

Avoro Capital Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 6,387,790 shares — an estimated $93.9M sold.

Avoro Capital Advisors first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $93.9M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Avoro Capital Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Avoro Capital Advisors sold 6,387,790 89bio shares in Q4 2025, an estimated $93.9M.
  • Avoro Capital Advisors first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • Avoro Capital Advisors's 89bio position peaked at $93.9M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Avoro Capital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.